JPMorgan Chase & Co

Company JPM

Last mentioned: Mar 6, 2026

Timeline

Mar 6, 2026
JPMorgan Disclosure

JPMorgan Chase & Co. reveals its $12.55 million position in the company.
Feb 25, 2026
Insider Activity

CEO Serge Saxonov sells 9,632 shares under a standard trading plan.
Feb 22, 2026
Syon Capital Entry

Syon Capital LLC discloses a new stake in TXG, adding to institutional support.
Feb 20, 2026
Market Momentum

10x Genomics shares trade up 6.4% as market sentiment begins to shift.

Stories mentioning JPMorgan Chase & Co 1

pharma Neutral

JPMorgan Discloses $12.55M Stake in 10x Genomics Amid Sector Volatility

JPMorgan Chase & Co. has established a significant $12.55 million position in 10x Genomics, signaling institutional confidence in the spatial biology leader. This move comes as the biotech tools sector navigates a complex landscape of patent litigation and shifting R&D budgets.

Mar 6, 2026 2 sources